These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30929534)

  • 81. Arthroscopic synovectomy for recurrent hemarthrosis of the ankle in hemophilia.
    Patti JE; Mayo WE
    Arthroscopy; 1996 Dec; 12(6):652-6. PubMed ID: 9115550
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Rheumatological management of patients with hemophilia. Part 1: joint manifestations.
    Alcalay M; Deplas A
    Joint Bone Spine; 2002 Oct; 69(5):442-9. PubMed ID: 12477227
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prophylaxis in haemophilia with inhibitors: update from international experience.
    Carcao M; Lambert T
    Haemophilia; 2010 Mar; 16 Suppl 2():16-23. PubMed ID: 20132334
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Experiences in the prevention of arthropathy in haemophila patients with inhibitors.
    Jimenez-Yuste V; Rodriguez-Merchan EC; Alvarez MT; Quintana M; Martin-Salces M; Hernandez-Navarro F
    Haemophilia; 2008 Nov; 14 Suppl 6():28-35. PubMed ID: 19134031
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Successful hemostasis during a major orthopedic operation by using recombinant activated factor VII in a patient with severe hemophilia A and a potent inhibitor.
    O'Marcaigh AS; Schmalz BJ; Shaughnessy WJ; Gilchrist GS
    Mayo Clin Proc; 1994 Jul; 69(7):641-4. PubMed ID: 8015327
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Arthroscopic synovectomy for hemophilic joint disease in a pediatric population.
    Dunn AL; Busch MT; Wyly JB; Sullivan KM; Abshire TC
    J Pediatr Orthop; 2004; 24(4):414-26. PubMed ID: 15205625
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Hemophilic arthropathy of the foot and ankle.
    Zimbler S; McVerry B; Levine P
    Orthop Clin North Am; 1976 Oct; 7(4):985-97. PubMed ID: 980433
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Bypassing agent prophylaxis for preventing arthropathy in patients with inhibitors.
    Ewenstein BM; Wong WY; Schoppmann A
    Haemophilia; 2010 Jan; 16(1):179-80. PubMed ID: 19702885
    [No Abstract]   [Full Text] [Related]  

  • 89. Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.
    Valentino LA; Cooper DL; Goldstein B
    Haemophilia; 2011 Jul; 17(4):579-89. PubMed ID: 21294815
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Isotopic synovectomy with P-32 in paediatric patients with haemophilia.
    Mathew P; Talbut DC; Frogameni A; Singer D; Chrissos M; Khuder S; Ohler S; Farley D; Michael C; Robinson MG
    Haemophilia; 2000 Sep; 6(5):547-55. PubMed ID: 11012700
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Management of factor VIII inhibitors: evolution and current status.
    Bloom AL
    Haemostasis; 1992; 22(5):268-75. PubMed ID: 1478538
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Literature review of surgery management in inhibitor patients.
    Rodriguez-Merchan EC; Rocino A
    Haemophilia; 2004 Sep; 10 Suppl 2():22-9. PubMed ID: 15385043
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Prevention of joint damage in hemophilic children with early prophylaxis].
    Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
    Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Orthopedic interventions in patients with hemophilia].
    Panotopoulos J; Trieb K
    Wien Med Wochenschr; 2003; 153(9-10):225-31. PubMed ID: 12836461
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cost and outcome: comparisons of two alternative bypassing agents for persons with haemophilia A complicated by an inhibitor.
    Steen Carlsson K; Astermark J; Donfield S; Berntorp E
    Thromb Haemost; 2008 Jun; 99(6):1060-7. PubMed ID: 18521509
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Prevention of haemophilic arthropathy in haemophilic children with inhibitors.
    Rodriguez-Merchan EC
    Haemophilia; 2008 Nov; 14 Suppl 6():1-3. PubMed ID: 19134025
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Evidence-based use of recombinant FVIIa (NovoSeven, NiaStase) for the treatment of hemophilia with inhibitors in children and adolescents.
    Goldstein B; Geldziler B; Bjerre J; Seremetis S
    Transfus Apher Sci; 2008 Feb; 38(1):25-32. PubMed ID: 18267372
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Surgery in haemophilic patients with inhibitor: 20 years of experience.
    Quintana-Molina M; Martínez-Bahamonde F; González-García E; Romero-Garrido J; Villar-Camacho A; Jiménez-Yuste V; Fernández-Bello I; Hernández-Navarro F
    Haemophilia; 2004 Sep; 10 Suppl 2():30-40. PubMed ID: 15385044
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The promise and challenges of bioengineered recombinant clotting factors.
    Pipe SW
    J Thromb Haemost; 2005 Aug; 3(8):1692-701. PubMed ID: 16102035
    [TBL] [Abstract][Full Text] [Related]  

  • 100. What does the 'Cochrane database of systematic reviews' tell us about hemophilia?
    Rodriguez-Merchan EC
    Expert Rev Hematol; 2019 Nov; 12(11):919-922. PubMed ID: 31610130
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.